【摘要】 现代医学对肥胖的治疗以药物、手术等对症治疗为主，药品不良反应及副作用常见，且容易复发。中医药治疗遵循整体观念和辨证论治原则，基于证候进行个体化干预，多组分、多靶点进行调节，疗效确切，副作用小，具有独特的优势。《肥胖症诊疗指南(2024年版)》《肥胖症中医诊疗方案专家共识》《基于临床的肥胖症多学科诊疗共识(2021年版)》中均制订肥胖的中医药治疗方案，推荐使用参苓白术散、逍遥散、佩连麻黄汤、麻仁丸等中药用于肥胖的治疗。该文从脾、胃、肝、肾论治角度，检索2003—2025年中文文献，对上述推荐中药的临床应用进行归纳整理，以期为临床选方、用药提供参考。更多还原

【Abstract】 Modern medical treatments for obesity primarily focus on symptomatic approaches like pharmacotherapy and surgery, which often cause adverse reactions, side effects, and a high recurrence rate. Traditional Chinese Medicine(TCM) interventions, guided by the principles of holism and syndrome differentiation, deliver personalized treatments based on clinical patterns. Through multi-component and multi-target regulation, TCM offers proven efficacy with minimal side effects, demonstrating unique advantages. TCM treatment protocols for obesity have been established in the Obesity Diagnosis and Treatment Guidelines(2024 Edition),expert Consensus on TCM Diagnosis and Treatment of Obesity, and Multidisciplinary Diagnosis and Treatment Consensus for Obesity Based on Clinical Practice(2021 Edition). These guidelines recommend herbal formulas such as Shenling Baizhu San, Xiaoyao San, Peilian Mahuang Tang, and Maren Wan for obesity management. From the perspective of TCM pattern differentiation involving the spleen, stomach, liver, and kidney. This review summarizes clinical applications of the recommended formulas based on Chinese literature published between 2003 and 2025, aiming to provide references for clinical formula selection and medication.更多还原